Top compounds associated with response to LRRC53


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.05
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.069 0.05
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.069 0.05
mRNA BRD4132 CTRPv2 pan-cancer AAC 0.071 0.06
mRNA ML203 CTRPv2 pan-cancer AAC 0.071 0.06
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.058 0.06
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.06 0.06
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.058 0.07
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.083 0.07
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 0.07
Download CSV